Afghanistan

in page functions
[French]
 
Total population (2015) 32,006,788
Birth cohort (2015) 1,028,322
Surviving Infants (surviving to 1 year per year, 2015) 963,719
Infant mortality rate (deaths < 1 year per 1000 births, 2013) 70/1000
Child mortality rate (deaths < 5 years per 1000 births, 2013) 97/1000
World Bank Index, IDA (2012) 2.63
Gross Nation Income (per capita US$, 2013) 690
Co-financing status (2015) Low-income
No. of districts/territories (2014) 329

Gavi support for Afghanistan

Type of support

Approvals

2001-2020 (US$)
(30 Jun 2015)

Commitments

2001-2020 (US$)
(30 Jun 2015)

Disbursements

2000-2015 (US$)
(30 Jun 2015)

% Disbursed

(30 Jun 2015)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2017
Civil Society Organisation support (CSO) $3,590,500 $3,590,500 $3,892,300 108%
Health system strengthening (HSS 1) $34,100,000 $34,100,000 $34,100,000 100%
Health system strengthening (HSS 2) $15,914,478 $15,914,478 $15,914,478 100%
Immunisation services support (ISS) $14,025,300 $14,025,300 $13,855,800 99%
Injection safety support (INS) $1,676,500 $1,676,500 $1,676,500 100%
IPV (NVS) $1,956,500 $2,669,000 $889,726 45%
Measles SIA (NVS) $2,271,500 $2,271,500 $2,254,243 99%
Measles SIA - Operational costs (OPC) $3,574,500 $3,574,500 $3,574,000 100%
Penta (NVS) $63,004,605 $63,004,605 $58,721,688 93%
Pneumo (NVS) $44,127,458 $44,127,458 $53,423,121 121%
Tetra DTP-HepB (NVS) $9,903,633 $9,903,633 $9,903,633 100%
Vaccine Introduction Grant (VIG) $2,512,000 $2,512,000 $2,512,000 100%
Total $196,656,974 $197,369,474 $200,717,489

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Afghanistan DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2014)

Grade of confidence


N/A
DTP3 - Official country estimates (2014) 95%
M:F sex ratio at birth (2015) 1.06
Household survey: DTP3 coverage for male (2011) 41.60%
Household survey: DTP3 coverage for female (2011) 38.90%
Household survey: Last DTP3 survey (2011) 40%
% districts achieving > 80% DTP3 coverage (2014) 68%
% districts achieving < 50% DTP3 coverage (2014) 9%
Polio WHO/UNICEF estimates (2014) 75%

Breakdown of support

Non-vaccine support Vaccine support
38% 62%
$75,525,078 $125,192,409

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Afghanistan

20 August 2015

Pakistan IPV

More than four million children per year in Pakistan to benefit from new injectable polio vaccine

Polio-endemic country takes another step towards a polio-free future as it introduces IPV into its routine immunisation programme, as part of largest globally coordinated vaccine introduction in history (joint press release Pakistan MoH, UNICEF, GPEI, WHO, Gavi).

12 August 2015

png20

More than 200,000 Papua New Guinea children to be protected with the new polio and measles-rubella vaccines

In a landmark step to help accelerate the global eradication of polio and protect its children against measles and rubella, Papua New Guinea introduces the inactivated polio vaccine (IPV) into its routine immunisation programme and launches a nationwide measles-rubella vaccine (MR) campaign.

26 June 2015

Cote d Ivoire - IPV launch

Enhanced polio protection to reach 650,000 Côte d’Ivoire children every year

Côte d’Ivoire is introducing the inactivated polio vaccine (IPV) into its routine immunisation programme.

close icon

modal window here